UC Irvine: UCI launches Center for Data-Driven Drugs Research and Policy. “UCI has launched the Center for Data-Driven Drugs Research and Policy to accelerate research that tackles pressing individual and population health challenges and to address the lack of diversity in biomedical studies.”
Stanford Law School: Who counts as an inventor?. “New research, undertaken by an interdisciplinary team of Stanford Law and Stanford Medicine students, looks at the overlap between biomedical research paper authors and those authors who go on to be named inventors of their research on patents. Among the findings is a gender discrepancy between male and female authors, with male authors receiving patents more frequently. The team created a comprehensive patent-to-publication citation map that includes 430,000 biomedical inventor-research teams.”
Scripps Research: Scripps Research develops behind-the-scenes tool for better biomedical data discovery. “This new tool, called the Data Discovery Engine (DDE) Schema Playground, was described in a paper that published in BMC Bioinformatics on April 20, 2023. The DDE Schema Playground is a browser-based resource that empowers scientists to make their data more findable and accessible on the web, which has been a significant barrier in the past.”
Florida State University: FSU’s ‘Art in STEM’ returns for ninth year with in-person and virtual exhibitions. “The nearly two dozen works depict topics ranging from crystal growth to nanotechnology and chemical compounds and were created by students from the FSU departments of biological science, biomedical sciences, chemistry and biochemistry, mathematics, molecular biophysics, nutrition and integrative physiology, and scientific computing.”
Yale School of Medicine: Introducing Jot — a new open-source tool that help researchers with journal selection. “Say hello to Jot: a free, open-source web application that matches manuscripts in the fields of biomedicine and life sciences with suitable journals, based on a manuscript’s title, abstract, and (optionally) citations. Developed by the Townsend Lab at the Yale School of Public Health, Jot gathers a wealth of data on journal quality, impact, fit, and open access options that can be explored through a dashboard of linked, interactive visualizations.”
Morgridge Institute for Research: New search app gleans ‘collective consciousness’ from a massive research database. “The PubMed database contains more than 33 million papers that represent the ‘collective consciousness’ of what humans know about biomedicine. It is impossible for researchers to keep up with this vast literature where more than 1,000 new papers get added daily. A new web application, KinderMiner Web, developed by Ron Stewart’s Bioinformatics Group at the Morgridge Institute for Research, gives researchers a fighting chance.”
New York Times: Making New Drugs With a Dose of Artificial Intelligence. “You can think of it as a World Cup of biochemical research. Every two years, hundreds of scientists enter a global competition. Tackling a biological puzzle they call ‘the protein folding problem,’ they try to predict the three-dimensional shape of proteins in the human body. No one knows how to solve the problem. Even the winners only chip away at it. But a solution could streamline the way scientists create new medicines and fight disease.”
NIH: NIH makes STRIDES to accelerate discoveries in the cloud. “The National Institutes of Health has launched a new initiative to harness the power of commercial cloud computing and provide NIH biomedical researchers access to the most advanced, cost-effective computational infrastructure, tools and services available. The STRIDES (Science and Technology Research Infrastructure for Discovery, Experimentation, and Sustainability) Initiative launches with Google Cloud as its first industry partner and aims to reduce economic and technological barriers to accessing and computing on large biomedical data sets to accelerate biomedical advances.”
PR Newswire: Journal of Biomedical Optics and Neurophotonics to become fully open access journals (PRESS RELEASE). “SPIE, the international society for optics and photonics, has announced that its Journal of Biomedical Optics and Neurophotonics will become fully open access journals in January 2019. The Journal of Biomedical Optics (JBO) has been published since 1996 and is edited by Lihong Wang of California Institute of Technology. Brian Pogue of Dartmouth College will assume the JBO editorship starting in January 2018. JBO publishes peer-reviewed papers on the use of modern optical technology for improved health care and biomedical research. Neurophotonics, edited by David Boas of Boston University, was launched by SPIE in 2014, and covers optical technologies applicable to study of the brain and their impact on the basic and clinical neuroscience applications.”
The National Institutes of Health have launched World Report. (Though on the actual site it’s called World RePORT.) “The project is intended to provide a public means to track international research activities and partnered investments, increase awareness of funding opportunities and share results with the broader research and funding community. In addition to providing information about direct awards, World Report also tracks indirect research activity, which often occurs in collaborations between the domestic research organizations and foreign institutions. The goal is to improve understanding of the research landscape, identify gaps in funding and areas where there might be a duplication of effort, and enable funders to more effectively synergize investments.” The focus, as you might expect, is biomedical research.
GlaxoSmithKline and Alphabet are teaming up to create a new company. “GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics. Verily Life Sciences – known as Google’s life sciences unit until last year – and Britain’s biggest drugmaker will together contribute 540 million pounds ($715 million) over seven years to Galvani Bioelectronics, they said on Monday.”
Interested in crowdsourcing? Interested in fighting cancer? Here ya go.
“The Challenge tackles three key questions about the sub-clonality of cancer: how many subclones are within any given tumour, how did these subclones grow and evolve, and which genetic mutations are present in each subclones? Using a method to simulate DNA sequencing data that closely mimics data from real human tumours, which was initially developed as part of a previous DREAM challenge, the team has created a set of 50 tumours with distinctive life-histories and evolutions. Contestants will create tools in the cloud using Google Compute Engine that will be run in Galaxy, a widely-used open-source platform for performing biomedical research. Contestants will also use Docker images to setup the environment for their tool to run in, allowing the tools to easily be ported to other systems. Further, the use of Docker images and the tools’ compatibility with Galaxy ensures that all submissions are immediately usable after the Challenge, creating a new library of algorithms that researchers can use in future studies and allowing the results of these studies to be compared in an objective way.”
Looks like Google/Alphabet’s getting deeper into life science and biomedicine. “[Jessica] Mega’s decision to move in March to Google was one in a string of announcements by top-flight scientists and physicians who are enlisting in the mission, and pioneering a new type of career path in the process. Although academic researchers from fields such as computer science and engineering have led innovative Google projects (such as the Internet-connected eyewear known as Glass), Google and other technology companies are increasingly recruiting life scientists as Silicon Valley broadens its reach into health care.”